2006 Update of ASCO Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer.
出版信息
J Oncol Pract. 2006 Nov;2(6):314-316. doi: 10.1200/JOP.2006.2.6.314.
Abstract
摘要
相似文献
1
2006 Update of ASCO Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer.美国临床肿瘤学会（ASCO）关于胃肠道癌肿瘤标志物使用建议的2006年更新版
J Oncol Pract. 2006 Nov;2(6):314-316. doi: 10.1200/JOP.2006.2.6.314.
2
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.美国临床肿瘤学会（ASCO）2006年关于肿瘤标志物在胃肠道癌中应用的推荐更新
J Clin Oncol. 2006 Nov 20;24(33):5313-27. doi: 10.1200/JCO.2006.08.2644. Epub 2006 Oct 23.
3
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.美国临床肿瘤学会政策声明更新：癌症易感性基因检测
J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11.
4
1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology.1997年乳腺癌和结直肠癌肿瘤标志物使用建议更新版。1997年11月7日由美国临床肿瘤学会采用。
J Clin Oncol. 1998 Feb;16(2):793-5. doi: 10.1200/JCO.1998.16.2.793.
5
Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update.骨修饰药物在转移性乳腺癌中的作用：美国临床肿瘤学会-加拿大安大略癌症护理焦点指南更新。
J Clin Oncol. 2017 Dec 10;35(35):3978-3986. doi: 10.1200/JCO.2017.75.4614. Epub 2017 Oct 16.
6
Updated 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing increase HER2 positive and HER2 equivocal breast cancer cases; retrospective study of HER2 FISH results of 836 invasive breast cancers.2013年美国病理学家学会/美国临床肿瘤学会（CAP/ASCO）关于人表皮生长因子受体2（HER2）荧光原位杂交（FISH）检测的更新指南建议增加了HER2阳性和HER2不确定的乳腺癌病例；836例浸润性乳腺癌HER2 FISH结果的回顾性研究
Breast Cancer Res Treat. 2016 Jun;157(3):405-11. doi: 10.1007/s10549-016-3824-x. Epub 2016 May 14.
7
[Breast cancer and molecular markers].[乳腺癌与分子标志物]
Gan To Kagaku Ryoho. 2008 Aug;35(8):1261-8.
8
American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines.美国临床肿瘤学会1998年乳腺癌监测指南更新版。
J Clin Oncol. 1999 Mar;17(3):1080-2. doi: 10.1200/JCO.1999.17.3.1080.
9
2005 Update of ASCO Practice Guideline Recommendations for Colorectal Cancer Surveillance: Guideline Summary.美国临床肿瘤学会（ASCO）结直肠癌监测指南建议2005年更新：指南摘要
J Oncol Pract. 2005 Nov;1(4):137-139. doi: 10.1200/JOP.2005.1.4.137.
10
Are Physicians Choosing Wisely When Imaging for Distant Metastases in Women With Operable Breast Cancer?对于可手术治疗的乳腺癌女性，医生在进行远处转移影像学检查时是否做出了明智选择？
J Oncol Pract. 2015 Jan;11(1):62-8. doi: 10.1200/JOP.2014.000125. Epub 2014 Nov 12.
引用本文的文献
1
Circulating lncRNA ABHD11-AS1 serves as a biomarker for early pancreatic cancer diagnosis.循环lncRNA ABHD11-AS1作为早期胰腺癌诊断的生物标志物。
J Cancer. 2019 Jun 9;10(16):3746-3756. doi: 10.7150/jca.32052. eCollection 2019.
2
Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.EGAPP工作组的建议：针对新诊断的结直肠癌患者的基因检测策略，旨在降低亲属患林奇综合征的发病率和死亡率。
Genet Med. 2009 Jan;11(1):35-41. doi: 10.1097/GIM.0b013e31818fa2ff.
Zotero 插件